100 TECHNOLOGY SQUARE, CAMBRIDGE, MA
Investor Presentation
Announces Second Quarter 2025 Financial Results and Recent Business Highlights
Shareholder votes
Tectonic Therapeutic's Positive Phase 1b Results for TX45 in Pulmonary Hypertension
Earnings Release
Annual Report to Security Holders
Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Announces $185 Million Private Placement
Q2
Q1
FY 2024
Q3
FY 2023
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement